Skip to main content

Table 1 Perioperative characteristics of the patients

From: Protective mechanical ventilation with optimal PEEP during RARP improves oxygenation and pulmonary indexes

Variables

Phase 1 (n=25)

Phase 2

Traditional ventilation (n=32)

Protective ventilation (n=32)

P (within phase 2)

Age (years)

68.6±7.6

69.9±6.8

70.3±6.4

0.441

 Range

60–84

60–83

60–82

 

Weight (kg)

67.8±9.0

64.2±9.1

63.1±9.1

0.242

BMI (kg/m2)

23.5±2.7

22.6±3.1

22.5±2.6

0.274

 Range

17.0–28.7

17.1–29.9

17.0–28.3

 

PBW (kg)

65.2±4.5

65.1±5.0

62.8±5.6

0.233

ASA grade

 II

24 (96%)

30 (93.8%)

30 (93.8%)

0.918

 III

1 (4%)

2 (6.3%)

2 (6.3%)

0.918

LVEF (%)

66.3±5.4

68.5±7.3

65.6±7.6

0.208

Hypertension

17 (68%)

18 (56.3%)

15 (46.9%)

0.280

Diabetes mellitus

7 (28%)

5 (15.6%)

4 (12.5%)

0.309

Coronary disease

0

2 (6.3%)

1 (3.1%)

0.429

Cerebral infarction

1 (4%)

2 (6.3%)

1 (3.1%)

0.828

Smoking history

   

0.458

 Never

14 (56.0%)

23 (71.9%)

21 (65.6%)

 

 Former

4 (16.0%)

3 (9.4%)

4 (12.5%)

 

 Current

7 (28.0%)

6 (18.7%)

7 (21.9%)

 

Operation time (min)

184.3±64.4

183.2±64.7

175.4±52.6

0.843

Postoperative hospital stay (days)

 

8.3±3.9

9.3±3.7

0.494

Estimated blood loss (ml)

138 (30–600)

89 (50–300)

100 (50–250)

0.249

Fluids (ml)

1790 (1200–3250)

1616 (1200–2800)

1605 (1100–2250)

0.314

Need for vaspressors (n)a

10 (40%)

12 (37.5%)

10 (31.3%)

0.772

Ephedrine total dose (mg)b

7.3±2.6

6.6±1.9

7.3±2.6

0.809

Phenylephrine total dose (ug)c

83.3±57.7

87.5±47.9

75.0±50.0

0.998

Duration of CO2 pneumoperitoneum (min)

135±58

143±56

129±43

0.686

  1. BMI Body mass index, PBW Predicted body weight, ASA American Society of Anesthesiologists, LVEF Left ventricular ejection fraction
  2. aNumber of patients who received ephedrine or phenylephrine
  3. bEphedrine dose represents the mean from patients who received ephedrine
  4. cPhenylephrine dose represents the mean from patients who received phenylephrine